Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
Rank in Stocks
#3531
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical... Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
Share Price
$3.79
Market Cap
$4.79B
Change (1 day)
-2.02%
Change (1 year)
-51.23%
Country
CN
Trade Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Category
Healthcare
Stock price history for Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Highest end of day price: $3.75 on 2026-10-01
Lowest end of day price: $0.55 on 2020-04-01
Lowest end of day price: $0.55 on 2020-04-01
Stock price history of Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. from 2020 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | -17.26% |
| 2025 | -35.40% |
| 2024 | 28.79% |
| 2023 | -42.24% |
| 2022 | -8.97% |
| 2021 | 74.48% |
| 2020 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.95 | -3.70% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
